"Designing Growth Strategies is in our DNA"

Acute Myeloid Leukemia Treatment Market Size, Share and Global Trend By Disease Type (Myeloblastic, Promyelocytic, Myelomonocytic), By Treatment Type (Chemotherapy, Targeted Therapy, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2024-2032

Region : Global | Report ID: FBI100607 | Status : Ongoing

 

KEY MARKET INSIGHTS

Leukemia is a type of cancer that mainly occurs in white blood cells. White blood cells function for the immune system and are produced in the bone marrow. In the case of leukemia, the bone marrow produces abnormal white blood cells. There are different types of leukemia based on their growth of the cells, namely acute (slow-growing) and chronic (fast-growing). Based on their growth in cells, they are classified as myeloid cells or lymphoid cells. Acute myeloid leukemia occurs in the bone marrow and rapidly spreads, affecting different parts of the body such as the liver, spleen, central nervous system, lymph nodes, and testicles.

To gain extensive insights into the market, Request for Customization

According to the American Cancer Society, in 2019, the number of new acute myeloid leukemia cases is estimated to be 21,450 in the U.S. The rising prevalence of acute myeloid leukemia and unmet needs of the patients have resulted in an increased focus on the development of new drugs. New drug approvals for the acute myeloid leukemia treatment, namely Rydapt by Novartis AG, is expected to drive the growth of global acute myeloid leukemia treatment market.

The rise in incidences of genetic mutations, sedentary lifestyles, high exposure to radiations are some factors leading to an increased incidence in acute myeloid leukemia globally. Moreover, the presence of potential pipeline candidates, new product launch, and increased investment by the pharmaceutical industry and research institutes are also expected to boost the market in the forecast duration.

However, high cost associated with stem cell transplantation and risk of side effects from the drugs are the major factors restricting the growth in the global acute myeloid leukemia treatment market

KEY PLAYERS COVERED  


Some of the major companies that are present in the global acute myeloid leukemia treatment market are VERASTEM, INC., Genzyme Corporation, Neomed Management AS, Sunesis Pharmaceuticals Inc., Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc., and others.

SEGMENTATION


























SEGMENTATION


 DETAILS


By Disease Type


·      Myeloblastic

·      Promyelocytic

·      Myelomonocytic

·      Others


By Treatment Type


·      Chemotherapy

·      Targeted Therapy

·      Others


By Distribution Channel


·      Hospital Pharmacy

·      Retail Pharmacy

·      Online Pharmacy


By Geography


·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


                               

Based on the treatment type, the chemotherapy segment is expected to dominate the global acute myeloid leukemia treatment market owing to the increased availability of the drugs, increased preference and increased R&D investment for the development of innovative drugs.

KEY INSIGHTS


Prevalence of acute myeloid leukemia

The regulatory scenario for key countries

Reimbursement Scenario for key countries

New product launch

Pipeline overview

Patent snapshot

Recent industry developments such as partnerships, mergers, and acquisitions

REGIONAL ANALYSIS


North America is anticipated to hold a considerable share in the global acute myeloid leukemia treatment market during the forecast period due to the increasing demand, favorable health reimbursement, and strategic research collaborations. The acute myeloid leukemia treatment market in Europe is expected to expand owing to the active government support, increasing prevalence of the disease, and emphasis on early cancer diagnosis by government. Asia Pacific is estimated to register a remarkable growth in the projected duration owing to the developing health infrastructure and increased government expenditure for the treatment of cancer. Also, inclination towards targeted therapies than the traditional methods is anticipated to fuel the growth in global acute myeloid leukemia treatment market in Asia Pacific during the forecast period.


















Key Industry Developments



· In December 2018, Astellas Pharma Inc., launched XOSPATA (gilteritinib) for treating adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation in the U.S.

· In November 2018, Pfizer Inc. received FDA approval for Cglasdegib (Daurismo) for patients who are newly-diagnosed with acute myeloid leukemia (AML).

· In November 2018, Genentech, Inc. received FDA approval for the Venclexta for the treatment of patients who are newly-diagnosed with acute myeloid leukemia or patients who are not eligible for intensive induction chemotherapy.

· In April 2017, Novartis AG received FDA approval for Rydapt for patient with newly diagnosed acute myeloid leukemia (AML) with FLT3-mutation and certain types of systemic mastocytosis (SM)





  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Roche
Pfizer
Siemens Healthineers
iqvia
Ansell

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X